B.S. in biochemistry, focuses included peptide synthesis and GPCRs. Ph.D. in medicinal organic chemistry, developing the structure-activity relationship between estrogen receptor and antagonist ligands to disrupt dysregulated cancer tumors. Research has included novel drug design, molecular modeling, organic synthesis, characterization & analysis, cell culture, FP & MTT assays, gel electrophoresis & Western blotting, plasmid transformation & bacterial cell expression, and protein purification. My interests in research relate to understanding and studying cellular pathways and protein-protein interactions as they relate to both regulated and dysregulated system processes. I utilize a targeted drug design based on proteome maps, molecular modelling & screening to build structure-activity relationships to better understand these PPI with the ultimate goal of identifying future potential avenues for the fight against tumorgenesis.